Exosomal Galectin-3 promotes peritoneal metastases in gastric adenocarcinoma via microenvironment alterations

Yibo Fan(Fudan University), Jaffer A. Ajani(The University of Texas MD Anderson Cancer Center)

iScience

December 10, 2024

10.1016/j.isci.2024.111564

Cited by 4

Related Papers

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

|Journal of the National Comprehensive Cancer Network|2022|1.7k

Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

|Journal of the National Comprehensive Cancer Network|2019|1.1k

Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial

|The Lancet|2023|701

Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial

|Nature Medicine|2023|541

Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology

|Journal of the National Comprehensive Cancer Network|2023|494